Excellent
Fully Aligned
Patient Risk:
Low
Summary
All extracted claims are directly supported by FDA label Section 11 (DESCRIPTION), which defines Eliquis as (apixaban) and chemically describes apixaban.
Category Scores
Accurate Statements
Eliquis’s generic name is apixaban.
11 DESCRIPTION: “ELIQUIS (apixaban) …”
Eliquis is the brand name.
11 DESCRIPTION: “ELIQUIS (apixaban) …”
Apixaban is the active ingredient in Eliquis.
11 DESCRIPTION: “ELIQUIS (apixaban), a factor Xa (FXa) inhibitor …” and product descriptions referencing apixaban as the drug substance in formulations.
Apixaban is the medication’s generic/chemical name.
11 DESCRIPTION: “ELIQUIS (apixaban) … is chemically described as …”
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The evaluated claims are identity/label-definition statements (brand vs. drug substance) and do not assert dosing, contraindications, or safety actions.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement